ArticlePharmaceuticals (Basel, Switzerland)2023

Glibenclamide-Loaded Nanoparticles Reduce NLRP3 Inflammasome Activation and Modulate miR-223-3p/miR-7-1-5p Expression in THP-1 Cells.

Roberta Mancuso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.